Cargando…

Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients

INTRODUCTION: Disease-modifying treatments for Alzheimer's disease (AD) are likely to be offered only to patients with molecular evidence for Alzheimer pathology and expanded to patients with prodromal AD. We calculated the potential future costs of expanding the number of positron emission tom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wittenberg, Raphael, Knapp, Martin, Karagiannidou, Maria, Dickson, John, Schott, Jonathan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709060/ https://www.ncbi.nlm.nih.gov/pubmed/31463360 http://dx.doi.org/10.1016/j.trci.2019.06.001

Ejemplares similares

Neural and behavioral substrates of disorientation in mild cognitive impairment and Alzheimer's disease
por: Sousa, Amber, et al.
Publicado: (2015)

Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent training
por: Teixeira, Camila Vieira Ligo, et al.
Publicado: (2018)

Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
por: Wang, Guoqiao, et al.
Publicado: (2015)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Predicting mild cognitive impairment from spontaneous spoken utterances
por: Asgari, Meysam, et al.
Publicado: (2017)

Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager‐horticulturalists
por: Gatz, Margaret, et al.
Publicado: (2022)

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
por: Frontera, Jennifer A., et al.
Publicado: (2022)

Social Insurance for Long-term Care
por: Karagiannidou, Maria, et al.
Publicado: (2022)

Health Literacy Risk in Older Adults With and Without Mild Cognitive Impairment
por: Liu, Yong B., et al.
Publicado: (2019)

Differential medial temporal lobe morphometric predictors of item- and relational-encoded memories in healthy individuals and in individuals with mild cognitive impairment and Alzheimer's disease
por: Gomar, Jesus J., et al.
Publicado: (2017)

General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
por: Petkus, Andrew J., et al.
Publicado: (2019)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Marked gender differences in progression of mild cognitive impairment over 8 years
por: Lin, Katherine A., et al.
Publicado: (2015)

A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment
por: Pink, Anna, et al.
Publicado: (2021)

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT
por: Fortier, Mélanie, et al.
Publicado: (2020)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

MRI‐assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction
por: Elman, Jeremy A., et al.
Publicado: (2021)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Kinect Project: People with dementia or mild cognitive impairment learning to play group motion-based games
por: Dove, Erica, et al.
Publicado: (2019)

Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes
por: Bharthur Sanjay, Apoorva, et al.
Publicado: (2022)

Mild cognitive impairment among rural‐dwelling older adults in China: A community‐based study
por: Cong, Lin, et al.
Publicado: (2022)

A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol
por: Saito, Satoshi, et al.
Publicado: (2016)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment
por: Ozer, Seline, et al.
Publicado: (2016)

Combined mnemonic strategy training and high-definition transcranial direct current stimulation for memory deficits in mild cognitive impairment
por: Hampstead, Benjamin M., et al.
Publicado: (2017)

Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2019)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
por: Willis, Brian A., et al.
Publicado: (2018)

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
por: Ballard, Clive, et al.
Publicado: (2019)

A randomized controlled trial of combined executive function and memory training on the cognitive and noncognitive function of individuals with mild cognitive impairment: Study rationale and protocol design
por: Zhang, Haifeng, et al.
Publicado: (2018)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

Integrating Concepts in Biology: A Model for More Effective Ways to Introduce Students to Biology
por: Prestwich, K. N., et al.
Publicado: (2015)

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
por: Landen, Jaren W., et al.
Publicado: (2017)

Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial
por: Shadyab, Aladdin H., et al.
Publicado: (2021)

Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community‐based cohort study
por: Wang, Jiao, et al.
Publicado: (2022)

Systematic literature review of methodologies and data sources of existing economic models across the full spectrum of Alzheimer’s disease and dementia from apparently healthy through disease progression to end of life care: a systematic review protocol
por: Karagiannidou, Maria, et al.
Publicado: (2018)

Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
por: Maher-Edwards, Gareth, et al.
Publicado: (2015)

Rates of longitudinal change in (18)F‐flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease
por: Phillips, Jeffrey S., et al.
Publicado: (2021)

Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
por: Edmonds, Emily C., et al.
Publicado: (2017)

Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan
por: Osone, Akira, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u3k22llv544pn612o0jska1m58